|
 |
|
| Home > In Vitro Diagnostics |
| |
| |
|
| |
 In Vitro Diagnostics Market Research Reports |
Immunohematology and Infectious Disease Screening Market: Competitive Analysis of Major Suppliers and Emerging Market Entrants
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants....
|
 |
|
$2750.00 |
| |
|
|
|
Opportunities in the Japanese Immunoprotein Diagnostic
Testing Market
This new 234-page report from Venture Planning Group provides analysis of the Japanese immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
|
|
|
$2750.00 |
| |
|
|
|
Japan Therapeutic Drug Monitoring (TDM): Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts
This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the Japanese therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
|
|
|
$2750.00 |
| |
|
|
|
Japan Endocrine Function Market: Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts
This new 269-page report from VPGMarketResearch.com provides a comprehensive analysis in the Japanese endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers.
|
|
|
$2750.00 |
| |
|
|
|
Japan Drugs of Abuse: Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts
This new 260-page report from VPGMarketResearch.com provides a comprehensive analysis of the Japanese drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
|
|
|
$2750.00 |
| |
|
|
|
2021-2025 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies
The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.This new study from Venture Planning Group contains 430 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.
|
|
|
$2750.00 |
| |
|
|
|
Japan Immunoprotein Market: Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts
This new report from VPGMarketResearch.com provides analysis of the Japanese immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
|
|
|
$2750.00 |
| |
|
|
|
Microbiology Market: Competitive Analysis of Major Suppliers and Emerging Market Entrants
This new 90-page report from VPGMarketResearch.com provides insightful profiles of leading microbiology market players and recent market entrants....
|
|
|
$2750.00 |
| |
|
|
|
Germany Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test
This unique report from Venture Planning Group provides Germany sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$2650.00 |
| |
|
|
|
Japan Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test
This unique report from Venture Planning Group provides Japan sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$2650.00 |
| |
|
|
|
Japan Enteric Diseases: Market Outlook and Emerging Opportunities
About This Report This report presents detailed analysis of the Japanese Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia....
|
|
|
$2600.00 |
| |
|
|
|
Blood Typing, Grouping and Infectious Disease Screening Tests: Emerging Assays and Companies Developing New Technologies and Products
The report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.Contains 195 pages and 7 tables
|
|
|
$2500.00 |
| |
|
|
|
Innovative Blood Typing, Grouping and Infectious Disease Diagnostic Technologies and Emerging Markets
The report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.
|
|
|
$2500.00 |
| |
|
|
|
Italy Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test
This unique report from Venture Planning Group provides Italy sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$2500.00 |
| |
|
|
|
UK Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test
This unique report from Venture Planning Group provides UK sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$2500.00 |
| |
|
|
|
Leading Cancer Diagnostics Market Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants
This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.Contains 80 pages
|
|
|
$2500.00 |
| |
|
|
|
World Cancer Diagnostics Market Key Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants
This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
|
|
|
$2500.00 |
| |
|
|
|
Analysis of the Argentinean Cancer Diagnostics Market:
Sales Forecasts, Supplier Shares, Competitive Strategies
Analysis of the Argentinean Cancer Diagnostics Market is a new strategic analysis of the major business opportunities emerging in the Argentinean cancer diagnostics market during the next five years. The report examines trends in the Argentinean cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.
|
|
|
$2500.00 |
| |
|
|
|
|